环状RNA与生物传感器技术联合革新重性抑郁障碍诊断
本文综述环状RNA(circRNA)作为重性抑郁障碍(MDD)生物标志物的潜力,强调等速电泳等富集方法优于传统技术,并探讨circRNA与生物传感器技术整合以提高诊断准确性和效率。然而,基于circRNA的诊断临床转化面临体液低丰度、需高灵敏快速检测平台及缺乏标准化即时检测方法等挑战。
要点
- circRNA富集方法(如等速电泳)优于传统技术,有助提升MDD生物标志物检测。
- circRNA参与MDD病理生理过程,与生物传感器整合可提高诊断准确性和效率。
- 临床转化挑战包括circRNA体液低丰度、需高灵敏快速平台及缺乏标准化即时检测方法。
核心结论
- circRNA有潜力作为MDD生物标志物,与生物传感器技术整合可改善诊断准确性和效率。
- 基于circRNA的诊断临床转化仍面临低丰度、检测平台要求和标准化方法缺乏等挑战。
研究设计与样本
- 本文为综述,检索范围未在摘要中明确报告。
主要发现
- circRNA富集方法(特别是等速电泳)相比传统技术具有优势。
- circRNA在MDD病理生理过程中发挥复杂作用。
- circRNA与生物传感器技术整合可提高诊断准确性和效率。
临床怎么用
- circRNA检测方法及生物传感器整合有望用于MDD诊断,但需解决标准化和即时检测兼容性。
局限性
- circRNA在体液中丰度低。
- 需要高灵敏度和快速检测平台。
- 缺乏标准化、即时检测兼容的方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Major Depressive Disorder (MDD) is a globally widespread mental health disorder that frequently remains underdiagnosed and inadequately treated. Recent advancements in circular RNAs (circRNAs) have illuminated their potential as biomarkers for a variety of diseases, including MDD. This review emphasizes the advantages of circRNA enrichment methodologies over traditional techniques, particularly isotachophoresis. Furthermore, the intricate role of circRNAs in the pathophysiological processes underlying MDD, as well as their integration with biosensor technology to improve diagnostic accuracy and efficiency, are synthesised. However, the clinical translation of circRNA-based diagnostics faces significant challenges, including the low abundance of circRNAs in bodily fluids, the need for highly sensitive and rapid detection platforms, and the lack of standardized, point-of-care compatible methods. A comprehensive overview of current circRNA detection methods, delineating their similarities and differences, is discussed. Insights for the anticipated advancements in quantitative and rapid circRNA detection is proposed. This review not only presents a thorough assessment of emerging trends in circRNA detection but also elaborates on primary techniques, traditional approaches, and recent innovations within the field of biosensor-based MDD diagnostics.
引用
- Zhu W, Wang Y, Yu C, et al. Revolutionizing MDD diagnosis: the integrated role of circRNAs and biosensor technology. Mol Psychiatry. 2026. PMID: 42120555. doi:10.1038/s41380-026-03581-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。